Advanced search
Publication Cover
Health Psychology and Behavioral Medicine
An Open Access Journal
Volume 10, 2022 - Issue 1
Submit an article Journal homepage
908
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Understanding cancer genetic risk assessment motivations in a remote tailored risk communication and navigation intervention randomized controlled trial

Circe Gray Le Comptea Biobehavioral Cancer Health Equity Research Lab, Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, NJ, USAView further author information
,
Shou-En Lub Rutgers Environmental Epidemiology and Statistics, Rutgers University School of Public Health, Rutgers, The State University of New Jersey University, New Brunswick, NJ, USAView further author information
,
Julianne Ania Biobehavioral Cancer Health Equity Research Lab, Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, NJ, USAView further author information
,
Jean McDougallc Department of Internal Medicine, Division of Epidemiology, Biostatistics, and Preventive Medicine, University of New Mexico, Albuquerque, NM, USAView further author information
,
Scott T. Waltersd Department of Health Behavior and Health Systems, University of North Texas Health Science Center, Fort Worth, TX, USAView further author information
,
Deborah Toppmeyere Stacy Goldstein Breast Cancer Center, LIFE Center, Medical Oncology, Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, NJ, USAView further author information
,
Tawny W. Boycef Biostatistics Shared Resource, UNM Comprehensive Cancer Center, University of New Mexico, Albuquerque, NM, USAView further author information
,
Antoinette Stroupg New Jersey State Cancer Registry, Stroup Research Center, Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, NJ, USAView further author information
,
Lisa Paddockh Cancer Surveillance Research Program, Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, NJ, USAView further author information
,
Sherry Grumeti LIFE Center, Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, NJ, USAView further author information
,
Yong Linj Department of Biostatistics and Epidemiology, School of Public Health, Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey University, New Brunswick, NJ, USAView further author information
,
Emily Heidta Biobehavioral Cancer Health Equity Research Lab, Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, NJ, USAView further author information
&
Anita Y. Kinneyj Department of Biostatistics and Epidemiology, School of Public Health, Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey University, New Brunswick, NJ, USACorrespondence[email protected]
View further author information
 show all
Pages 1190-1215 | Received 19 Jul 2022, Accepted 13 Nov 2022, Published online: 09 Dec 2022

References

  • Acharya, A., Blackwell, M., & Sen, M. (2016). Explaining causal findings without bias: Detecting and assessing direct effects. American Political Science Review, 110(3), 512–529. https://doi.org/10.1017/S0003055416000216
  • Acharya, A., Sounderajah, V., Ashrafian, H., Darzi, A., & Judah, G. (2021). A systematic review of interventions to improve breast cancer screening health behaviours. Preventive Medicine, 153, Article 106828. https://doi.org/10.1016/j.ypmed.2021.106828
  • Anderson-Lewis, C., Darville, G., Mercado, R. E., Howell, S., & Di Maggio, S. (2018). mHealth technology use and implications in historically underserved and minority populations in the United States: Systematic literature review. JMIR Mhealth and Uhealth, 6(6), e128. https://doi.org/10.2196/mhealth.8383. PubMed PMID: 29914860; PMCID: PMC6028762.
  • Baser, R. E., Li, Y., Brennessel, D., Kemeny, M. M., & Hay, J. L. (2019). Measurement invariance of intuitive cancer risk perceptions across diverse populations: The cognitive causation and negative affect in risk scales. Journal of Health Psychology, 24(9), 1221–1232. https://doi.org/10.1177/1359105317693910. PubMed PMID: 28810422; PMCID: PMC7906483.
  • Birmingham, W. C., Hung, M., Boonyasiriwat, W., Kohlmann, W., Walters, S. T., Burt, R. W., Stroup, A. M., Edwards, S. L., Schwartz, M. D., Lowery, J. T., Hill, D. A., Wiggins, C. L., Higginbotham, J. C., Tang, P., Hon, S. D., Franklin, J. D., Vernon, S., & Kinney, A. Y. (2015). Effectiveness of the extended parallel process model in promoting colorectal cancer screening. Psycho-oncology, 24(10), 1265–1278. https://doi.org/10.1002/pon.3899. PubMed PMID: 26194469; PMCID: PMC7161702.
  • Boonyasiriwat, W., Hung, M., Hon, S. D., Tang, P., Pappas, L. M., Burt, R. W., Schwartz, M. D., Stroup, A. M., & Kinney, A. Y. (2014). Intention to undergo colonoscopy screening among relatives of colorectal cancer cases: A theory-based model. Annals of Behavioral Medicine, 47(3), 280–291. https://doi.org/10.1007/s12160-013-9562-y. PubMed PMID: 24307472.
  • Boutron, I., Altman, D. G., Moher, D., Schulz, K. F., & Ravaud, P. (2017). CONSORT statement for randomized trials of nonpharmacologic treatments: A 2017 update and a CONSORT extension for nonpharmacologic trial abstracts. Annals of Internal Medicine, 167(1), 40–47. https://doi.org/10.7326/M17-0046. PubMed PMID: 28630973.
  • Brumbach, B. H., Birmingham, W. C., Boonyasiriwat, W., Walters, S., & Kinney, A. Y. (2017). Intervention mediators in a randomized controlled trial to increase colonoscopy uptake among individuals at increased risk of familial colorectal cancer. Annals of Behavioral Medicine, 51(5), 694–706. https://doi.org/10.1007/s12160-017-9893-1. PubMed PMID: 28236077.
  • Carpenter, C. R., & Sherbino, J. (2010). How does an ‘opinion leader’ influence my practice? Canadian Journal of Emergency Medicine, 12(5), 431–434. https://doi.org/10.1017/S1481803500012586
  • Caruso, A., Vigna, C., & Gremigni, P. (2018). The cancer worry scale revised for breast cancer genetic counseling. Cancer Nursing, 41(4), 311–319. https://doi.org/10.1097/NCC.0000000000000511. PubMed PMID: 28538002.
  • Chavarria, E. A., Christy, S. M., Simmons, V. N., Vadaparampil, S. T., Gwede, C. K., & Meade, C. D. (2021). Learner verification: A methodology to create suitable education materials. Health Literacy Research and Practice, 5(1), e49–e59. https://doi.org/10.3928/24748307-20210201-02. PubMed PMID: 34251862; PMCID: PMC8075101.
  • Chew, L. D., Bradley, K. A., & Boyko, E. J. (2004, September). Brief questions to identify patients with inadequate health literacy. Family Medicine, 36(8), 588–594.
  • Childers, C. P., Childers, K. K., Maggard-Gibbons, M., & Macinko, J. (2017). National estimates of genetic testing in women with a history of breast or ovarian cancer. Journal of Clinical Oncology, 35(34), 3800–3806. https://doi.org/10.1200/JCO.2017.73.6314. PubMed PMID: 28820644; PMCID: PMC5707208.
  • Cragun, D., Kinney, A. Y., & Pal, T. (2017). Care delivery considerations for widespread and equitable implementation of inherited cancer predisposition testing. Expert Review of Molecular Diagnostics, 17(1), 57–70. https://doi.org/10.1080/14737159.2017.1267567. PubMed PMID: 27910721; PMCID: PMC5642111.
  • Cragun, D., Weidner, A., Kechik, J., & Pal, T. (2019). Genetic testing across young Hispanic and non-Hispanic white breast cancer survivors: Facilitators, barriers, and awareness of the Genetic Information Nondiscrimination Act. Genetic Testing and Molecular Biomarkers, 23(2), 75–83. https://doi.org/10.1089/gtmb.2018.0253. PubMed PMID: 30676117.
  • Daly, M. B., Pilarski, R., Berry, M., Buys, S. S., Farmer, M., Friedman, S., Garber, J. E., Kauff, N. D., Khan, S., Klein, C., Kohlmann, W., Kurian, A., Litton, J. K., Madlensky, L., Merajver, S. D., Offit, K., Pal, T., Reiser, G., Shannon, K. M., … Darlow, S. (2017). NCCN guidelines insights: Genetic/familial high-risk assessment: Breast and ovarian, version 2.2017. Journal of the National Comprehensive Cancer Network: JNCCN, 15(1), 9–20. https://doi.org/10.6004/jnccn.2017.0003. PubMed PMID: 28040716.
  • Delikurt, T., Williamson, G. R., Anastasiadou, V., & Skirton, H. (2015). A systematic review of factors that act as barriers to patient referral to genetic services. European Journal of Human Genetics, 23(6), 739–745. https://doi.org/10.1038/ejhg.2014.180
  • Dwyer, A. A., Shen, H., Zeng, Z., Gregas, M., & Zhao, M. (2021). Framing effects on decision-making for diagnostic genetic testing: Results from a randomized trial. Genes, 12(6), 941. https://doi.org/10.3390/genes12060941
  • Evans, J. (1996). Straightforward statistics for the behavioral sciences. Brooks/Cole Publishing.
  • Finch, A. P. M., Lubinski, J., Møller, P., Singer, C. F., Karlan, B., Senter, L., Rosen, B., Maehle, L., Ghadirian, P., Cybulski, C., Huzarski, T., Eisen, A., Foulkes, W. D., Kim-Sing, C., Ainsworth, P., Tung, N., Lynch, H. T., Neuhausen, S., Metcalfe, K. A., … Narod, S. A. (2014). Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation. Journal of Clinical Oncology, 32(15), 1547–1553. https://doi.org/10.1200/JCO.2013.53.2820. PubMed PMID: 24567435; PMCID: PMC4026578.
  • Flores, K. G., Steffen, L. E., McLouth, C. J., Vicuña, B. E., Gammon, A., Kohlmann, W., Vigil, L., Dayao, Z. R., Royce, M. E., & Kinney, A. Y. (2017). Factors associated with interest in gene-panel testing and risk communication preferences in women from BRCA1/2 negative families. Journal of Genetic Counseling, 26(3), 480–490. https://doi.org/10.1007/s10897-016-0001-7. PubMed PMID: 27496122; PMCID: PMC5293684.
  • Gollwitzer, P. M. B. J. (1996). The psychology of action: Linking cognition and motivation to behavior. Guilford Press.
  • Gómez-Trillos, S., Sheppard, V. B., Graves, K. D., Song, M., Anderson, L., Ostrove, N., Lopez, K., Campos, C., Gonzalez, N., & Hurtado-de-Mendoza, A. (2020). Latinas’ knowledge of and experiences with genetic cancer risk assessment: Barriers and facilitators. Journal of Genetic Counseling, 29(4), 505–517. https://doi.org/10.1002/jgc4.1201
  • Hann, K. E. J., Freeman, M., Fraser, L., Waller, J., Sanderson, S. C., Rahman, B., Side, L., Gessler, S., & Lanceley, A. (2017). Awareness, knowledge, perceptions, and attitudes towards genetic testing for cancer risk among ethnic minority groups: A systematic review. BMC Public Health, 17(1), 503. https://doi.org/10.1186/s12889-017-4375-8. PubMed PMID: 28545429; PMCID: PMC5445407.
  • Harris, P. A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., & Conde, J. G. (2009). Research electronic data capture (REDCap) – a metadata-driven methodology and workflow process for providing translational research informatics support. Journal of Biomedical Informatics, 42(2), 377–381. https://doi.org/10.1016/j.jbi.2008.08.010. PubMed PMID: 18929686; PMCID: PMC2700030.
  • Hoefel, L., O'Connor, A. M., Lewis, K. B., Boland, L., Sikora, L., Hu, J., & Stacey, D. (2020). 20th anniversary update of the Ottawa decision support framework part 1: A systematic review of the decisional needs of people making health or social decisions. Medical Decision Making, 40(5), 555–581. https://doi.org/10.1177/0272989(20936209. PubMed PMID: 32659154.
  • Imai, K., & Yamamoto, T. (2013). Identification and sensitivity analysis for multiple causal mechanisms: Revisiting evidence from framing experiments. Political Analysis, 21(2), 141–171. https://doi.org/10.1093/pan/mps040
  • Ji, F., Yang, C.-Q., Li, X.-L., Zhang, L.-L., Yang, M., Li, J.-Q., Gao, H.-F., Zhu, T., Cheng, M.-Y., Li, W.-P., Wu, S.-Y., Zhong, A.-L., & Wang, K. (2020). Risk of breast cancer-related death in women with a prior cancer. Aging, 12(7), 5894–5906. https://doi.org/10.18632/aging.102984
  • Kataoka, M. (2021). Editorial: HBOC and high-risk screening: Up-to-date. Breast Cancer, 28(6), 1165–1166. https://doi.org/10.1007/s12282-021-01284-3
  • Kinney, A. Y., Gammon, A., Coxworth, J., Simonsen, S. E., & Arce-Laretta, M. (2010). Exploring attitudes, beliefs, and communication preferences of Latino community members regarding BRCA1/2 mutation testing and preventive strategies. Genetics in Medicine, 12(2), 105–115. https://doi.org/10.1097/GIM.0b013e3181c9af2d. PubMed PMID: 20061960; PMCID: PMC3022322.
  • Kinney, A. Y., Howell, R., Ruckman, R., McDougall, J. A., Boyce, T. W., Vicuña, B., Lee, J.-H., Guest, D. D., Rycroft, R., Valverde, P. A., Gallegos, K. M., Meisner, A., Wiggins, C. L., Stroup, A., Paddock, L. E., & Walters, S. T. (2018). Promoting guideline-based cancer genetic risk assessment for hereditary breast and ovarian cancer in ethnically and geographically diverse cancer survivors: Rationale and design of a 3-arm randomized controlled trial. Contemporary Clinical Trials, 73, 123–135. https://doi.org/10.1016/j.cct.2018.09.005. PubMed PMID: 30236776; PMCID: PMC6214814.
  • Kinney, A. Y., Steffen, L. E., Brumbach, B. H., Kohlmann, W., Du, R., Lee, J.-H., Gammon, A., Butler, K., Buys, S. S., Stroup, A. M., Campo, R. A., Flores, K. G., Mandelblatt, J. S., & Schwartz, M. D. (2016). Randomized noninferiority trial of telephone delivery of BRCA1/2 genetic counseling compared with in-person counseling: 1-year follow-up. Journal of Clinical Oncology, 34(24), 2914–2924. https://doi.org/10.1200/JCO.2015.65.9557. PubMed PMID: 27325848; PMCID: PMC5012661.
  • Komenaka, I. K., Nodora, J. N., Madlensky, L., Winton, L. M., Heberer, M. A., Schwab, R. B., Weitzel, J. N., & Martinez, M. E. (2016). Participation of low-income women in genetic cancer risk assessment and BRCA 1/2 testing: The experience of a safety-net institution. Journal of Community Genetics, 7(3), 177–183. https://doi.org/10.1007/s12687-015-0257-x
  • Kuchenbaecker, K. B., Hopper, J. L., Barnes, D. R., Phillips, K.-A., Mooij, T. M., Roos-Blom, M.-J., Jervis, S., van Leeuwen, F. E., Milne, R. L., Andrieu, N., Goldgar, D. E., Terry, M. B., Rookus, M. A., Easton, D. F., Antoniou, A. C., McGuffog, L., Evans, D. G., Barrowdale, D., Frost, D., … Olsson, H. (2017). Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA, 317(23), 2402–2416. https://doi.org/10.1001/jama.2017.7112
  • Kumar, A., Guss, Z. D., Courtney, P. T., Nalawade, V., Sheridan, P., Sarkar, R. R., Banegas, M. P., Rose, B. S., Xu, R., & Murphy, J. D. (2020). Evaluation of the use of cancer registry data for comparative effectiveness research. JAMA Network Open, 3(7), e2011985. https://doi.org/10.1001/jamanetworkopen.2020.11985
  • Kurian, A. W., Griffith, K. A., Hamilton, A. S., Ward, K. C., Morrow, M., Katz, S. J., & Jagsi, R. (2017). Genetic testing and counseling among patients with newly diagnosed breast cancer. JAMA, 317(5), 531–534. https://doi.org/10.1001/jama.2016.16918
  • Langer, M. M., Roche, M. I., Brewer, N. T., Berg, J. S., Khan, C. M., Leos, C., Moore, E., Brown, M., & Rini, C. (2017). Development and validation of a genomic knowledge scale to advance informed decision-making research in genomic sequencing. MDM Policy & Practice, 2(1). https://doi.org/10.1177/2381468317692582. PubMed PMID: 29928697.
  • Litton, J. K., Rugo, H. S., Ettl, J., Hurvitz, S. A., Gonçalves, A., Lee, K.-H., Fehrenbacher, L., Yerushalmi, R., Mina, L. A., Martin, M., Roché, H., Im, Y.-H., Quek, R. G. W., Markova, D., Tudor, I. C., Hannah, A. L., Eiermann, W., & Blum, J. L. (2018). Talazoparib in patients with advanced breast cancer and a germline BRCA mutation. The New England Journal of Medicine, 379(8), 753–763. https://doi.org/10.1056/NEJMoa1802905. PubMed PMID: 30110579.
  • MacKinnon, D. P., Fritz, M. S., Williams, J., & Lockwood, C. M. (2007). Distribution of the product confidence limits for the indirect effect: Program PRODCLIN. Behavior Research Methods, 39(3), 384–389. https://doi.org/10.3758/bf03193007. PubMed PMID: 17958149; PMCID: PMC2819369.
  • Maloney, E. K., Lapinski, M. K., & Witte, K. (2011). Fear appeals and persuasion: A review and update of the extended parallel process model. Social and Personality Psychology Compass, 5(4), 206–219. https://doi.org/10.1111/j.1751-9004.2011.00341.x
  • Meissner, V. H., Olze, L., Schiele, S., Ankerst, D. P., Jahnen, M., Gschwend, J. E., Herkommer, K., & Dinkel, A. (2021). Fear of cancer recurrence and disease progression in long-term prostate cancer survivors after radical prostatectomy: A longitudinal study. Cancer, 127(22), 4287–4295. https://doi.org/10.1002/cncr.33836. PubMed PMID: 34358337.
  • Millar, M. M., Kinney, A. Y., Camp, N. J., Cannon-Albright, L. A., Hashibe, M., Penson, D. F., Kirchhoff, A. C., Neklason, D. W., Gilsenan, A. W., Dieck, G. S., Stroup, A. M., Edwards, S. L., Bateman, C., Carter, M. E., & Sweeney, C. (2019). Predictors of response outcomes for research recruitment through a central cancer registry: Evidence from 17 recruitment efforts for population-based studies. American Journal of Epidemiology, 188(5), 928–939. https://doi.org/10.1093/aje/kwz011. PubMed PMID: 30689685; PMCID: PMC6494669 .
  • Miller, W. R., & Rollnick, S. (2012). Motivational interviewing: Helping people change (3rd ed.). Guilford Press.
  • Moss, H. A., Samimi, G., Havrilesky, L. J., Sherman, M. E., & Myers, E. R. (2018). Estimating the number of potential family members eligible for BRCA1 and BRCA2 mutation testing in a ‘traceback’ approach. Genetic Epidemiology, 42(1), 117–122. https://doi.org/10.1002/gepi.22095. PubMed PMID: 29193313 .
  • National Comprehensive Cancer Network. (2021). Genetic/familial high-risk assessment: Breast, ovarian, and pancreatic. Version 2.2021. NCCN.org. Retrieved May 13, 2021, from https://www.nccn.org/professionals/physician_gls/pdf/genetics_bop.pdf.
  • Nelson, H. D., Pappas, M., Cantor, A., Haney, E., & Holmes, R. (2019). Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: Updated evidence report and systematic review for the US preventive services task force. JAMA, 322(7), 666–685. https://doi.org/10.1001/jama.2019.8430
  • Peshkin, B. N., Kelly, S., Nusbaum, R. H., Similuk, M., DeMarco, T. A., Hooker, G. W., Valdimarsdottir, H. B., Forman, A. D., Joines, J. R., Davis, C., McCormick, S. R., McKinnon, W., Graves, K. D., Isaacs, C., Garber, J., Wood, M., Jandorf, L., & Schwartz, M. D. (2016). Patient perceptions of telephone vs. in-person BRCA1/BRCA2 genetic counseling. Journal of Genetic Counseling, 25(3), 472–482. https://doi.org/10.1007/s10897-015-9897-6. PubMed PMID: 26455498; PMCID: PMC4829475.
  • Rees, I., Jones, D., Chen, H., & Macleod, U. (2018). Interventions to improve the uptake of cervical cancer screening among lower socioeconomic groups: A systematic review. Preventive Medicine, 111, 323–335. https://doi.org/10.1016/j.ypmed.2017.11.019. PubMed PMID: 29203349.
  • Robson, M., Im, S.-A., Senkus, E., Xu, B., Domchek, S. M., Masuda, N., Delaloge, S., Li, W., Tung, N., Armstrong, A., Wu, W., Goessl, C., Runswick, S., & Conte, P. (2017). Olaparib for metastatic breast cancer in patients with a germline BRCA mutation. The New England Journal of Medicine, 377(6), 523–533. https://doi.org/10.1056/NEJMoa1706450. PubMed PMID: 28578601.
  • Ryerson, A. B., Eheman, C., Styles, T., Rycroft, R., & Snyder, C. (2015). Connecting the dots: Linking the national program of cancer registries and the needs of survivors and clinicians. American Journal of Preventive Medicine, 49(6 Suppl 5), S528–S535. https://doi.org/10.1016/j.amepre.2015.08.026. PubMed PMID: 26590648; PMCID: PMC4656128 .
  • Sabatino, S. A., Lawrence, B., Elder, R., Mercer, S. L., Wilson, K. M., DeVinney, B., Melillo, S., Carvalho, M., Taplin, S., Bastani, R., & Rimer, B. K. (2012). Effectiveness of interventions to increase screening for breast, cervical, and colorectal cancers: Nine updated systematic reviews for the guide to community preventive services. American Journal of Preventive Medicine, 43(1), 97–118. https://doi.org/10.1016/j.amepre.2012.04.009. PubMed PMID: 22704754.
  • Samimi, G., Bernardini, M. Q., Brody, L. C., Caga-anan, C. F., Campbell, I. G., Chenevix-Trench, G., Couch, F. J., Dean, M., de Hullu, J. A., Domchek, S. M., Drapkin, R., Spencer Feigelson, H., Friedlander, M., Gaudet, M. M., Harmsen, M. G., Hurley, K., James, P. A., Kwon, J. S., Lacbawan, F., … Sherman, M. E. (2017). Traceback: A proposed framework to increase identification and genetic counseling of BRCA1 and BRCA2 mutation carriers through family-based outreach. Journal of Clinical Oncology, 35(20), 2329–2337. https://doi.org/10.1200/JCO.2016.70.3439. PubMed PMID: 28398847; PMCID: PMC5501360.
  • Schwarzer, R., & Hamilton, K. (2020). Changing behavior using the health action process approach. In K. Hamilton, L. D. Cameron, M. S. Hagger, N. Hankonen, & T. Lintunen (Eds.), The handbook of behavior change (pp. 89–103). Cambridge University Press.
  • Schwarzer, R., Lippke, S., & Ziegelmann, J. P. (2008). Health action process approach: A research agenda at the freie universitat Berlin to examine and promote health behavior change. Gesundheitspsychologie, 16(3), 157–160. https://doi.org/10.1026/0943-8149.16.3.157
  • Shen, L., Condit, C. M., & Wright, L. (2009). The psychometric property and validation of a fatalism scale. Psychology & Health, 24(5), 597–613. https://doi.org/10.1080/08870440801902535
  • Smith-Uffen, M., Bartley, N., Davies, G., & Best, M. (2021). Motivations and barriers to pursue cancer genomic testing: A systematic review. Patient Education and Counseling, 104(6), 1325–1334. https://doi.org/10.1016/j.pec.2020.12.024. PubMed PMID: 33390305.
  • Spencer, J. C., & Wheeler, S. B. (2016). A systematic review of motivational interviewing interventions in cancer patients and survivors. Patient Education and Counseling, 99(7), 1099–1105. https://doi.org/10.1016/j.pec.2016.02.003. PubMed PMID: 26879805.
  • Stacey, D., Légaré, F., Boland, L., Lewis, K. B., Loiselle, M.-C., Hoefel, L., Garvelink, M., & O’Connor, A. (2020). 20th anniversary Ottawa decision support framework: Part 3 overview of systematic reviews and updated framework. Medical Decision Making, 40(3), 379–398. https://doi.org/10.1177/0272989X20911870. PubMed PMID: 32428429.
  • Steffen, L. E., Boucher, K. M., Damron, B. H., Pappas, L. M., Walters, S. T., Flores, K. G., Boonyasiriwat, W., Vernon, S. W., Stroup, A. M., Schwartz, M. D., Edwards, S. L., Kohlmann, W. K., Lowery, J. T., Wiggins, C. L., Hill, D. A., Higginbotham, J. C., Burt, R., Simmons, R. G., & Kinney, A. Y. (2015). Efficacy of a telehealth intervention on colonoscopy uptake when cost is a barrier: The family CARE cluster randomized controlled trial. Cancer Epidemiology, Biomarkers, & Prevention, 24(9), 1311–1318. https://doi.org/10.1158/1055-9965.Epi-15-0150. PubMed PMID: 26101306; PMCID: PMC4734378.
  • Sutton, A. L., He, J., Tanner, E., Edmonds, M. C., Henderson, A., de Mendoza, A. H., & Sheppard, V. B. (2019). Understanding medical mistrust in black women at risk of BRCA 1/2 mutations. Journal of Health Disparities Research and Practice, 12(3), 35–47. PubMed PMID: 32995070; PMCID: PMC7521839.
  • Takeuchi, E., Kim, Y., Shaffer, K. M., Cannady, R. S., & Carver, C. S. (2020). Fear of cancer recurrence promotes cancer screening behaviors among family caregivers of cancer survivors. Cancer, 126(8), 1784–1792. https://doi.org/10.1002/cncr.32701. PubMed PMID: 31913499; PMCID: PMC7103484.
  • Tavakol, M., & Dennick, R. (2011). Making sense of cronbach's alpha. International Journal of Medical Education, 2, 53–55. https://doi.org/10.5116/ijme.4dfb.8dfd. PubMed PMID: 28029643; PMCID: PMC4205511.
  • Tofighi, D., & MacKinnon, D. P. (2011). RMediation: An R package for mediation analysis confidence intervals. Behavior Research Methods, 43(3), 692–700. https://doi.org/10.3758/s13428-011-0076-x. PubMed PMID: 21487904; PMCID: PMC3233842.
  • Trask, P. C., Rabin, C., Rogers, M. L., Whiteley, J., Nash, J., Frierson, G., & Pinto, B. (2005). Cancer screening practices among cancer survivors. American Journal of Preventive Medicine, 28(4), 351–356. https://doi.org/10.1016/j.amepre.2005.01.005. PubMed PMID: 15831340.
  • Tung, N., Lin, N. U., Kidd, J., Allen, B. A., Singh, N., Wenstrup, R. J., Hartman, A.-R., Winer, E. P., & Garber, J. E. (2016). Frequency of germline mutations in 25 cancer susceptibility genes in a sequential series of patients with breast cancer. Journal of Clinical Oncology, 34(13), 1460–1468. https://doi.org/10.1200/JCO.2015.65.0747. PubMed PMID: 26976419.
  • U.S. Department of Agriculture. (2000). Rural-urban commuting area codes. Retrieved on November 23, 2022, from https://www.ers.usda.gov/data-products/rural-urban-commuting-area-codes.aspx
  • US Preventive Services Task Force. (2019). Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer: US preventive services task force recommendation statement. JAMA, 322(7), 652–665. https://doi.org/10.1001/jama.2019.10987
  • Witte, K. (1992). Putting the fear back into fear appeals: The extended parallel process model. Communication Monographs, 59(4), 329–349. https://doi.org/10.1080/03637759209376276
  • Witte, K., & Allen, M. (2000). A meta-analysis of fear appeals: Implications for effective public health campaigns. Health Education & Behavior, 27(5), 591–615. https://doi.org/10.1177/109019810002700506. PubMed PMID: 11009129.
  • Witte, K., Meyer, G., & Martell, D. (2001). Effective health risk messages: A step-by-step guide. Sage. https://sk.sagepub.com/books/effective-health-risk-messages
  • Wood, M. E., Vogel, V., Ng, A., Foxhall, L., Goodwin, P., & Travis, L. B. (2012). Second malignant neoplasms: Assessment and strategies for risk reduction. Journal of Clinical Oncology, 30(30), 3734–3745. https://doi.org/10.1200/JCO.2012.41.8681.
  • Zhang, C. Q., Zhang, R., Schwarzer, R., & Hagger, M. S. (2019). A meta-analysis of the health action process approach. Health Psychology, 38(7), 623–637. doi:10.1037/hea0000728. PubMed PMID: 30973747.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.